Treatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood

Abstract

Purpose

We retrospectively studied patients with myoclonic-astatic epilepsy of early childhood (MAE) to investigate the most effective treatment and long-term seizure and intellectual prognosis.

Subjects

Eighty-one patients with MAE were recruited from among 3600 patients with childhood epilepsy according to the ILAE criteria of MAE.

Methods

We retrospectively investigated the clinical characteristics and ultimate prognosis of the patients with MAE from the medical records. The effects of various antiepileptic drugs, ketogenic diet and ACTH treatments on myoclonic-astatic seizures (MS/AS), apparently a hallmark of this unique epileptic syndrome, were also studied.

Results

MS/AS in 89 % of the patients disappeared within 1 to 3 years despite initial resistance, but generalized tonic-clonic or clonic seizures [G(T)CS] tended to continue. The most effective treatment for the MS/AS was ketogenic diet, followed by ACTH and ESM. At the last follow-up, 55 patients or 68 % of all the patients had remission of epilepsy, 11 patients or 14 % experienced a recurrence of GTCS after a long remission period but easily regained control, and the remaining 15 patients or 18 % continued to have seizures and intellectual outcomes were poor. In one half of these patients with poor outcomes, repeated minor epileptic status and nocturnal generalized tonic seizures persisted. A family history of epilepsy and a combination of minor epileptic status are risk factors for poor outcomes.

Conclusion

MAE is considered to form a clinical spectrum ranging in its main seizure type from myoclonic to atonic, and in seizure and intellectual outcomes from benign to malignant. The overall prognosis, despite initial resistance to treatment, appears to be much better than originally thought when ILAE definitions excluding SME are followed.

Myoclonic-Astatic Epilepsy - Long-Term Prognosis - Treatment Response - Myoclonic-Astatic Seizures - Doose Syndrome

References

• 1 Aicardi J, Chevrie J J. Myoclonic epilepsies of childhood.  Neuropediatrie. 1971;  3 177-190
• 2 Aicardi J. Course and prognosis of certain childhood epilepsies with predominantly myoclonic seizures. Wada JA, Penry JK Advances in Epileptology: Xth Epilepsy International Symposium. New York; Raven Press 1980: 159-163
• 3 Aicardi J. Lennox-Gastaut syndrome. Aicardi J Epilepsy in children. New York; Raven Press 1992: 44-66
• 4 Aicardi J. Myoclonic epilepsies of infancy and early childhood. Aicardi J Epilepsy in Children. New York; Raven Press 1992: 67-79
• 5 Dalla Bernardina B, Capovilla G, Chiamenti C, Trevisan E, Colamaria V, Fontana E. Cryptogenic myoclonic epilepsies of infancy and childhood; Nosological and prognostic approach. Wolf P, Dam M, Janz D, Dreifuss FE Advances in Epileptology: XVIth Epilepsy International Symposium. New York; Raven Press 1986: 175-179
• 6 Doose H, Gerken H, Leonhardt R, Voltzke E, Volz C. Centrencephalic myoclonic-astatic petit mal.  Neuropediatrie. 1970;  2 59-78
• 7 Doose H, Baier W K. Genetic factors in epilepsies with primarily generalized minor seizures.  Neuropediatrics. 1987;  18 1-64
• 8 Doose H. Myoclonic astatic epilepsy of early childhood. Roger J, Dravet C, Bureau M, Dreifuss FE, Wolf P Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed. London, Paris; John Libbey Eurotext Ltd 1992: 103-114
• 9 Doose H. Myoclonic-astatic epilepsy.  Epilepsy Res. 1992;  6 (Suppl) 163-168
• 10 Dravet C, Roger J, Bureau M, Dalla Bernardina B. Myoclonic epilepsies in childhood. Akimoto H, Kazamatsuri H, Seino M, Ward A Advances in Epileptology: XIIIth Epilepsy International Symposium. New York; Raven Press 1982: 135-140
• 11 Dravet C, Bureau M, Roger J. Benign myoclonic epilepsy in infants. Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed. London; John Libbey 1992: 67-74
• 12 Dravet C, Bureau M, Roger J. Severe myoclonic epilepsy in infants. Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed. London; John Libbey 1992: 75-88
• 13 Dulac O, N'Guyen T. The Lennox-Gastaut syndrome.  Epilepsia. 1993;  34 (Suppl 7) 7-17
• 14 Dulac O, Kaminska A. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes.  J Child Neurol. 1997;  12 (Suppl 1) 23-28
• 15 Dulac O, Plouin P, Shewmon A. Myoclonus and epilepsy in childhood: 1996 Royaumont meeting.  Epilepsy Res. 1998;  30 91-106
• 16 Egli M, Mothersill I, O'Kane M, O'Kane F. The axial spasm - the predominant type of drop seizure in patients with secondary generalized epilepsy.  Epilepsia. 1985;  26 401-415
• 17 Guerrini R, Dravet C, Gobbi G, Ricci S, Dulac O. Idiopathic generalized epilepsies with myoclonus in infancy and childhood. Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. London; John Libbey & Company Lt 1994: 267-280
• 18 Harper J R. True myoclonic epilepsy in childhood.  Arch Dis Childh. 1968;  43 28-35
• 19 Ikeno T, Shigematsu H, Miyakoshi M. et al . An analytic study of epileptic falls.  Epilepsia. 1985;  26 612-621
• 20 Jeavons P M. Nosological problems of myoclonic epilepsies in childhood and adolescence.  Dev Med Child Neurol. 1977;  19 3-8
• 21 Kaminska A, Ickowicz A, Plouin P, Bru M F, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis.  Epilepsy Res. 1999;  36 15-29
• 22 Lin Y, Itomi K, Takada H, Kuboda T, Okumura A, Aso K, Negoro T, Watanabe K. Benign myoclonic epilepsy in infants: video-EEG features and long-term follow-up.  Neuropediatrics. 1998;  29 268-271
• 23 Lombroso C T. Early myoclonic encephalopathy, early epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies; critical review and personal contribution.  J Clin Neurophysiol. 1990;  7 380-408
• 24 Oguni H, Fukuyama Y. A clinical and electroencephalographic study of myoclonic epilepsies in infancy and early childhood: Part 1. On the classification [in Japanese].  J Jpn Epil Soc. 1989;  7 67-76
• 25 Oguni H, Fukuyama Y. A clinical and electroencephalographic study of myoclonic epilepsies in infancy and early childhood: Part 2. Idiopathic myoclonic epilepsy with benign prognosis [in Japanese].  J Jpn Epil Soc. 1989;  7 77-88
• 26 Oguni H, Fukuyama Y, Imaizumi Y, Uehara T. A video-EEG analysis of drop seizures in myoclonic astatic epilepsy of early childhood (Doose syndrome).  Epilepsia. 1992;  33 805-813
• 27 Oguni H, Imaizumi Y, Uehara T, Oguni M, Fukuyama Y. Electroencephalographic features of epileptic drop attacks and absence seizures: a case study.  Brain Dev. 1993;  15 226-230
• 28 Oguni H, Kitami H, Oguni M, Mukahira A, Uehara T, Fukuyama Y. et al . Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant.  Epilepsia. 1994;  35 1140-1145
• 29 Oguni H, Kitami H, Osawa M. Long-term prognosis of Lennox-Gastaut syndrome.  Epilepsia. 1996;  37 (Suppl 3) 44-47
• 30 Oguni H, Uehara T, Imai K. Osawa M. Atonic epileptic drop attacks associated with generalized spike-and-wave complexes: video-polygraphic study in two patients.  Epilepsia. 1997;  38 813-818
• 31 Oguni H, Hayashi K, Awaya Y, Fukuyama Y, Osawa M. Severe myoclonic epilepsy in infants - a review based on the Tokyo Women's Medical University series of 84 cases.  Brain Dev. 2001;  23 736-748
• 32 Oguni H, Fukuyama Y, Tanaka T, Hayashi K, Funatsuka M, Sakauchi M. et al . Myoclonic-astatic epilepsy of early childhood - clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome.  Brain Dev. 2001;  23 757-764
• 33 Ohki T, Watanabe K, Negoro K, Aso K, Haga Y, Kasai K. et al . Severe myoclonic epilepsy in infancy: evolution of seizures.  Seizure. 1997;  6 219-224
• 34 Proposal for revised classification of epilepsies and epileptic syndromes; Commission on classification and terminology of the international league against epilepsy.  Epilepsia. 1989;  30 389-399
• 35 Rossi G P, Gobbi G, Melideo G, Parmeggiani A, Tullini A, Santucci M. Myoclonic manifestations in the Lennox-Gastaut syndrome and other childhood epilepsies. Niedermeyer E, Degen R The Lennox-Gastaut Syndrome. New York; Alan R. Liss 1988: 137-158
• 36 Rossi G P, Parmeggiani A, Posar A, Santi A, Santucci M. Benign myoclonic epilepsy: long-term follow-up of 11 new cases.  Brain Dev. 1997;  19 473-479
• 37 Rowan A J, Meijer J WA, de Beer-Pawlikowski, van der Geest P, Meinardi H. Valproate-ethosuximide combination therapy for refractory absence seizures.  Arch Neurol. 1983;  40 797-802
• 38 Scheffer I E, Wallace R, Mulley J C, Berkovic S F. Clinical and molecular genetics of myoclonic-astatic epilepsy and severe myoclonic epilepsy in infancy (Dravet syndrome).  Brain Dev. 2001;  23 732-735
• 39 Vining E P. Clinical efficacy of the ketogenic diet.  Epilepsy Res. 1999;  37 181-190
• 40 Wallace S J. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide.  Epilepsy Res. 1998;  29 147-154
• 41 Yamatogi Y, Ohtsuka Y, Ishida T. et al . Treatment of the Lennox-Gastaut syndrome with ACTH: Clinical and electroencephalographic study.  Brain Dev. 1979;  1 267-276